Market Tracker

04/24 6:02pm ET

Ocata Therapeutics Inc (NASDAQ:OCAT)

7.48
Delayed Data
As of Apr 24
 +0.02 / +0.27%
Today’s Change
4.95
Today|||52-Week Range
12.73
+22.82%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close7.46
Today’s open7.51
Day’s range7.39 - 7.52
Volume116,506
Average volume (3 months)168,836
Market cap$261.4M
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)0.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-51.77%
P/E ratioNM
Price/Sales683.37
Price/Book17.16

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc-0.04-1.60%
ECYTEndocyte Inc-0.13-2.06%
POZNPOZEN Inc+0.08+0.96%
ZGNXZogenix Inc-0.11-6.67%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$225.0K
Annual profit (last year)-$31.0M
Net profit margin-13,788.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts